Aehr Test Systems

Day range

$53.00 – $58.55

Open

$55.34

Prev close

$55.31

Volume

1.32M

Market cap

$1.81B

Shares out

32.66M

P/E

—

P/S

36.51

P/B

13.02

P/FCF

—

ROE

-6.6%

ROA

-5.8%

Debt/Equity

0.00

Div yield

0.00%

As of Oct 23, 2026

• Annual meeting resultsOct 20, 2026

  “Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.” “The foregoing proposal was approved.”

• Public offeringApr 20, 2026

  On April 17, 2026, Aehr Test Systems, a California corporation (the "Company"), fully utilized its previously announced at-the-market equity offering program and completed sales of shares of its common stock having aggregate gross proceeds of approximately $60.0 million. The shares were offered and sold pursuant to the Company's effective registration statement on Form S-3 (File No. 333-282661), which registered up to $100.0 million of securities, and the prospectus supplement dated April 8, 2026.

• Underwriting agreementApr 8, 2026

  On April 8, 2026, AEHR Test Systems (the "Company") entered into an equity distribution agreement (the "Equity Distribution Agreement") with William Blair & Company, L.L.C. and Craig-Hallum Capital Group LLC (the "Agents"), in connection with the offer and sale of up to $60,000,000 of shares of the Company's common stock.

• Fiscal year changeApr 7, 2026

  On April 2, 2026, the Board of Directors of the Company approved a change in the Company's fiscal year end from the 52- or 53-week period ending on the Friday nearest May 31 to the 52- or 53-week period ending on the Friday nearest June 30. The change will be effective beginning in fiscal year 2027, which will begin on June 27, 2026 and end on June 25, 2027 (the "New Fiscal Year"). As a result of the change, the Company will have a 28-day transition period beginning on May 30, 2026, and ending on June 26, 2026 (the "Transition Period").

• Guidance issuance or updateJan 8, 2026

  Press Release dated January 8, 2026, announcing the Company's fiscal 2026 second quarter financial results and reinstatement of fiscal 2026 guidance

Days to cover

2.4

Short interest

5.22M

Avg volume

2.16M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Implied Volatility Surging for Aehr Stock Options
  neutralZacks Investment Research· Oct 13, 2026
• AEHR vs. CAMT: Which Semiconductor Equipment Stock Is the Better Bet?
  positiveZacks Investment Research· Sep 30, 2026
• AEHR at 18.59X Sales: Market Loves Its AI Story, But is Love Blind?
  neutralZacks Investment Research· Sep 21, 2026
• Can AEHR's Diversification Strengthen Its Growth Outlook?
  positiveZacks Investment Research· Sep 14, 2026
• Aehr Test Systems Insider Sells $847,000 Worth of Stock
  positiveThe Motley Fool· Aug 31, 2026